00359nam a2200121Ia 4500008004100000245010100041260001800142260000900160300000800169500000900177650001300186856003800199170516s9999    xx            000 0 und d  aAnalytical Challenges and Regulatory Requirements for Nasal Drug Products in Europe and the U.S.  bPharmaceutics  c2014  a6:2  aJune  xPharmacy  uhttp://www.mdpi.com/1999-4923/6/2